Diseases and Treatment
Inhaled “Immunoantimicrobial” Investigated for COPD
Experimental, inhaled nanoparticles that incorporate antimicrobial peptides (AMPs) and encapsulate an antibiotic were demonstrated to penetrate mucus and biofilm barriers to quell infection...
Positive Impact of Antiviral Therapy in Multiple Sclerosis
Øivind Torkildsen, MD, PhDThis article originally appeared on our sister site, NeurologyLive.A recently published case report of a patient with highly active multiple...
Top Infectious Disease Stories: Week of February 5
This week, a study advocates enhancing hospital cleaning protocols to halt healthcare-associated infections; integrating HCV testing and antivirals in prisons to cut transmission...
Exebacase Combined With Antibiotics Fails to Improve MRSA Bacteremia Outcomes
In a DISTRUPT clinical trial investigating new treatments for MRSA infections, a phase 3 study revealed that the antistaphylococcal lysin exebacase, when combined...
Addressing Disparities in HIV Mortality
Since the introduction of ART in 1996, mortality rates among people with HIV have significantly declined. A new study goes into the trends...
Efforts to Increase COVID-19 Antiviral Accessibility
In the battle against COVID-19, antiviral drugs have emerged as a clinical tool in preventing the progression from mild-to-moderate disease to severe illness,...